Skip to content
The Nexus
DossierENTITY

MindMaze Therapeutics

Coverage of MindMaze Therapeutics in the Nexus archive.

Earliest in view: Jul 17 · 18:10 UTCMost recent: Jul 17 · 18:10 UTC
Co-mentioned in this coverage
Zach Hendersonperson1Connect Labs by Wexfordorganization1The Pearl innovation districtplace1Charlotteplace1Lausanneplace1neurotherapeutic technologytopic1stroketopic1Alzheimer diseasetopic1Parkinson diseasetopic1
Recent coverage
  • BUSINESSJul 17 · 18:10 UTCWSOC ABC CHARLOTTE
    $1B Swiss biotech establishes US headquarters in the Queen City

    Swiss biotech company MindMaze Therapeutics has established its U.S. headquarters in Charlotte's The Pearl innovation district. The company, which focuses on neurotherapeutic technology for stroke, Alzheimer disease, and Parkinson disease, opened a Patient Experience Center in May at Connect Labs by Wexford.

MindMaze Therapeutics · Dossier · The Nexus